Lu C, Chen Q, Zhou T, et al. Micro-electrode array recordings reveal reductions in both excitation and inhibition in cultured cortical neuron networks lacking Shank3. Mol Psychiatry. 2016;21(2):159-68. doi:10.1038/mp.2015.173
Zhou Y, Kaiser T, Monteiro P, et al. Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects. Neuron. 2016;89(1):147-62. doi:10.1016/j.neuron.2015.11.023
Randlett O, Wee CL, Naumann EA, et al. Whole-brain activity mapping onto a zebrafish brain atlas. Nat Methods. 2015;12(11):1039-46. doi:10.1038/nmeth.3581
Kim MJ, Biag J, Fass DM, et al. Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity. Mol Psychiatry. 2017;22(3):417-429. doi:10.1038/mp.2016.98
Zhang X, Chen MH, Wu X, et al. Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. Cell. 2016;166(5):1147-1162.e15. doi:10.1016/j.cell.2016.07.025
Lodato MA, Woodworth MB, Lee S, et al. Somatic mutation in single human neurons tracks developmental and transcriptional history. Science. 2015;350(6256):94-8. doi:10.1126/science.aab1785
Hong S, Stevens B. Microglia: Phagocytosing to Clear, Sculpt, and Eliminate. Dev Cell. 2016;38(2):126-8. doi:10.1016/j.devcel.2016.07.006
Ataman B, Boulting GL, Harmin DA, et al. Evolution of Osteocrin as an activity-regulated factor in the primate brain. Nature. 2016;539(7628):242-247. doi:10.1038/nature20111
Bhatt S, Gupta MK, Khamaisi M, et al. Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes. Cell Metab. 2015;22(2):239-52. doi:10.1016/j.cmet.2015.07.015
Andreadis A, Wagner BK, Broderick JA, Kosik KS. A tau promoter region without neuronal specificity. J Neurochem. 1996;66(6):2257-63.